Elevated circulating oxidized LDL levels in Japanese subjects with the metabolic syndrome

International Journal of Cardiology

Volumn 118, Issue 2, 2007, Pages 270-272

  Yamagishi, Sho ichi ^a   Matsuoka, Hidehiro ^a   Kitano, Soichi ^b   Hibi, Nozomu ^b   Jinnouchi, Yuko ^a   Umei, Hidekazu ^a   Iida, Shuji ^a   Takenaka, Katsuhiko ^a   Matsui, Takanori ^a   Nakamura, Kazuo ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IVD   (Japan)

Author keywords

Atherosclerosis; Insulin resistance; Oxidative stress

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD CHEMISTRY; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; JAPANESE; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERIES; CHOLESTEROL, LDL; FEMALE; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; SEX DISTRIBUTION; TUNICA INTIMA;

EID: 34247175405     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.058     Document Type: Article

References (13)

1. Scheen A.J. Management of the metabolic syndrome. Minerva Endocrinol 29 (2004) 31-45
2. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
3. Hansel B., Giral P., Nobecourt E., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89 (2004) 4963-7491
4. Kato T., Inoue T., Yamagishi S., Murooka T., Okimoto T., and Node K. Low-density lipoprotein subfractions and the prevalence of silent lucunar infarction in subjects with essential hypertension. Hypertens Res 29 (2006) 303-307
5. Adachi H., Hirai Y., Fujiura Y., Matsuoka H., Satoh A., and Imaizumi T. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 33 (2002) 2177-2181
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 106 (2002) 3143-3421
7. Grundy S.M., Cleeman C.J., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
8. Lamarche B., Lemieux I., and Despres J.P. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 25 (1999) 199-211
9. Holvoet P., Kritchevsky S.B., Tracy R.P., et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53 (2004) 1068-1073
10. Boizel R., Benhamou P.Y., Lardy B., Laporte F., Foulon T., and Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 23 (2002) 1679-1685
11. Shashkin P., Dragulev B., and Ley K. Macrophage differentiation to foam cells. Curr Pharm Des 11 (2005) 3061-3072
12. Mango R., Clementi F., Borgiani P., et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 40 (2003) 933-936
13. Chen Q., Reis S.E., Kammerer C., et al. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 107 (2003) 3146-3151